BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

679 related articles for article (PubMed ID: 31337953)

  • 41. Identification of prostate cancer hub genes and therapeutic agents using bioinformatics approach.
    Fang E; Zhang X; Wang Q; Wang D
    Cancer Biomark; 2017 Dec; 20(4):553-561. PubMed ID: 28800317
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of potential therapeutic targets associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
    Sharma A; Yadav D; Rao P; Sinha S; Goswami D; Rawal RM; Shrivastava N
    Comput Biol Med; 2022 Jul; 146():105688. PubMed ID: 35680454
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Integrated bioinformatics analysis reveals key candidate genes and pathways in breast cancer.
    Wang Y; Zhang Y; Huang Q; Li C
    Mol Med Rep; 2018 Jun; 17(6):8091-8100. PubMed ID: 29693125
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prediction of a miRNA-mRNA functional synergistic network for cervical squamous cell carcinoma.
    Sun D; Han L; Cao R; Wang H; Jiang J; Deng Y; Yu X
    FEBS Open Bio; 2019 Dec; 9(12):2080-2092. PubMed ID: 31642613
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of Differentially Expressed Genes (DEGs) Relevant to Prognosis of Ovarian Cancer by Use of Integrated Bioinformatics Analysis and Validation by Immunohistochemistry Assay.
    Zhang L; Sun L; Zhang B; Chen L
    Med Sci Monit; 2019 Dec; 25():9902-9912. PubMed ID: 31871312
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pathway crosstalk analysis in prostate cancer based on protein-protein network data.
    Li HY; Jin N; Han YP; Jin XF
    Neoplasma; 2017; 64(1):22-31. PubMed ID: 27881001
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
    Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
    Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bioinformatics Analysis and Identification of Genes and Molecular Pathways Involved in Synovial Inflammation in Rheumatoid Arthritis.
    Xiong Y; Mi BB; Liu MF; Xue H; Wu QP; Liu GH
    Med Sci Monit; 2019 Mar; 25():2246-2256. PubMed ID: 30916045
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of Pivotal Genes and Pathways in Osteoarthritic Degenerative Meniscal Lesions via Bioinformatics Analysis of the GSE52042 Dataset.
    Huan X; Jinhe Y; Rongzong Z
    Med Sci Monit; 2019 Nov; 25():8891-8904. PubMed ID: 31758856
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High-efficient Screening Method for Identification of Key Genes in Breast Cancer Through Microarray and Bioinformatics.
    Liu Z; Liang G; Tan L; Su AN; Jiang W; Gong C
    Anticancer Res; 2017 Aug; 37(8):4329-4335. PubMed ID: 28739725
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Microarray gene expression profiling and bioinformatics analysis reveal key differentially expressed genes in clival and sacral chordoma cell lines.
    Li G; Cai L; Zhou L
    Neurol Res; 2019 Jun; 41(6):554-561. PubMed ID: 30821656
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of key genes and pathways of diagnosis and prognosis in cervical cancer by bioinformatics analysis.
    Yang HJ; Xue JM; Li J; Wan LH; Zhu YX
    Mol Genet Genomic Med; 2020 Jun; 8(6):e1200. PubMed ID: 32181600
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of Hub Genes in High-Grade Serous Ovarian Cancer Using Weighted Gene Co-Expression Network Analysis.
    Wu M; Sun Y; Wu J; Liu G
    Med Sci Monit; 2020 Mar; 26():e922107. PubMed ID: 32180586
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comprehensive bioinformatics analysis of acquired progesterone resistance in endometrial cancer cell line.
    Li W; Wang S; Qiu C; Liu Z; Zhou Q; Kong D; Ma X; Jiang J
    J Transl Med; 2019 Feb; 17(1):58. PubMed ID: 30813939
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Screening and function analysis of hub genes and pathways in hepatocellular carcinoma via bioinformatics approaches.
    Zhang L; Huang Y; Ling J; Zhuo W; Yu Z; Shao M; Luo Y; Zhu Y
    Cancer Biomark; 2018; 22(3):511-521. PubMed ID: 29843214
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of key genes and associated pathways in KIT/PDGFRA wild‑type gastrointestinal stromal tumors through bioinformatics analysis.
    Wang WJ; Li HT; Yu JP; Li YM; Han XP; Chen P; Yu WW; Chen WK; Jiao ZY; Liu HB
    Mol Med Rep; 2018 Nov; 18(5):4499-4515. PubMed ID: 30221743
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of Key Genes and Pathways in Tongue Squamous Cell Carcinoma Using Bioinformatics Analysis.
    Zhang H; Liu J; Fu X; Yang A
    Med Sci Monit; 2017 Dec; 23():5924-5932. PubMed ID: 29240723
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bioinformatics analysis identified hub genes in prostate cancer tumorigenesis and metastasis.
    Gu P; Yang D; Zhu J; Zhang M; He X
    Math Biosci Eng; 2021 Apr; 18(4):3180-3196. PubMed ID: 34198380
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of key microRNAs and genes in preeclampsia by bioinformatics analysis.
    Luo S; Cao N; Tang Y; Gu W
    PLoS One; 2017; 12(6):e0178549. PubMed ID: 28594854
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of key candidate genes and biological pathways in neuropathic pain.
    Cui CY; Liu X; Peng MH; Liu Q; Zhang Y
    Comput Biol Med; 2022 Nov; 150():106135. PubMed ID: 36166989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.